<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>E 범위결정과 핵심질문 | 삽화편두통 예방치료약물 진료지침</title>
  <meta name="description" content="Migraine prevention" />
  <meta name="generator" content="bookdown 0.11 and GitBook 2.6.7" />

  <meta property="og:title" content="E 범위결정과 핵심질문 | 삽화편두통 예방치료약물 진료지침" />
  <meta property="og:type" content="book" />
  
  <meta property="og:image" content="static/KHS_guideline_cover.pdf" />
  <meta property="og:description" content="Migraine prevention" />
  <meta name="github-repo" content="rstudio/bookdown-demo" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="E 범위결정과 핵심질문 | 삽화편두통 예방치료약물 진료지침" />
  
  <meta name="twitter:description" content="Migraine prevention" />
  <meta name="twitter:image" content="static/KHS_guideline_cover.pdf" />

<meta name="author" content="대한두통학회 편두통진료지침위원회" />


<meta name="date" content="2019-07-01" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="section-28.html">
<link rel="next" href="section-53.html">
<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">Prevention of Episodic Migraine</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i>머리말</a></li>
<li class="chapter" data-level="" data-path="section-1.html"><a href="section-1.html"><i class="fa fa-check"></i>발간사</a></li>
<li class="chapter" data-level="" data-path="section-2.html"><a href="section-2.html"><i class="fa fa-check"></i>간행사</a></li>
<li class="chapter" data-level="1" data-path="section-3.html"><a href="section-3.html"><i class="fa fa-check"></i><b>1</b> 요약</a><ul>
<li class="chapter" data-level="1.1" data-path="section-3.html"><a href="section-3.html#section-4"><i class="fa fa-check"></i><b>1.1</b> 핵심질문과 권고사항</a></li>
<li class="chapter" data-level="1.2" data-path="section-3.html"><a href="section-3.html#section-5"><i class="fa fa-check"></i><b>1.2</b> 약물별 권고수준</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path="section-6.html"><a href="section-6.html"><i class="fa fa-check"></i><b>2</b> 개요</a></li>
<li class="chapter" data-level="3" data-path="section-7.html"><a href="section-7.html"><i class="fa fa-check"></i><b>3</b> 각론</a><ul>
<li class="chapter" data-level="3.1" data-path="section-7.html"><a href="section-7.html#section-8"><i class="fa fa-check"></i><b>3.1</b> 핵심질문 1.</a></li>
<li class="chapter" data-level="3.2" data-path="section-7.html"><a href="section-7.html#section-10"><i class="fa fa-check"></i><b>3.2</b> 핵심질문 2.</a></li>
<li class="chapter" data-level="3.3" data-path="section-7.html"><a href="section-7.html#section-12"><i class="fa fa-check"></i><b>3.3</b> 핵심질문 3.</a></li>
<li class="chapter" data-level="3.4" data-path="section-7.html"><a href="section-7.html#section-14"><i class="fa fa-check"></i><b>3.4</b> 핵심질문 4.</a></li>
<li class="chapter" data-level="3.5" data-path="section-7.html"><a href="section-7.html#section-16"><i class="fa fa-check"></i><b>3.5</b> 핵심질문 5.</a></li>
<li class="chapter" data-level="3.6" data-path="section-7.html"><a href="section-7.html#section-17"><i class="fa fa-check"></i><b>3.6</b> 핵심질문 6.</a></li>
<li class="chapter" data-level="3.7" data-path="section-7.html"><a href="section-7.html#section-19"><i class="fa fa-check"></i><b>3.7</b> 핵심질문 7.</a></li>
</ul></li>
<li class="appendix"><span><b>Appendix</b></span></li>
<li class="chapter" data-level="A" data-path="section-21.html"><a href="section-21.html"><i class="fa fa-check"></i><b>A</b> 두통 일기</a></li>
<li class="chapter" data-level="B" data-path="section-22.html"><a href="section-22.html"><i class="fa fa-check"></i><b>B</b> 삽화편두통 예방약물의 용량, 부작용 및 금기사항</a><ul>
<li class="chapter" data-level="B.1" data-path="section-22.html"><a href="section-22.html#section-23"><i class="fa fa-check"></i><b>B.1</b> 일반적인 용량 및 흔한 부작용</a></li>
<li class="chapter" data-level="B.2" data-path="section-22.html"><a href="section-22.html#section-24"><i class="fa fa-check"></i><b>B.2</b> 금기사항</a></li>
</ul></li>
<li class="chapter" data-level="C" data-path="section-25.html"><a href="section-25.html"><i class="fa fa-check"></i><b>C</b> 편두통 진단기준</a><ul>
<li class="chapter" data-level="" data-path="section-25.html"><a href="section-25.html#korean-version-of-the-international-classification-of-headache-disorders-3rd-edition"><i class="fa fa-check"></i>Korean Version of The International Classification of Headache Disorders, 3rd Edition</a></li>
<li class="chapter" data-level="" data-path="section-25.html"><a href="section-25.html#section-26"><i class="fa fa-check"></i>무조짐 편두통</a></li>
<li class="chapter" data-level="" data-path="section-25.html"><a href="section-25.html#section-27"><i class="fa fa-check"></i>조짐 편두통</a></li>
</ul></li>
<li class="chapter" data-level="D" data-path="section-28.html"><a href="section-28.html"><i class="fa fa-check"></i><b>D</b> 지침 개발 과정</a><ul>
<li class="chapter" data-level="D.1" data-path="section-28.html"><a href="section-28.html#section-29"><i class="fa fa-check"></i><b>D.1</b> 이해당사자의 참여</a><ul>
<li class="chapter" data-level="D.1.1" data-path="section-28.html"><a href="section-28.html#section-30"><i class="fa fa-check"></i><b>D.1.1</b> 지침 제정 참여자 및 역할</a></li>
<li class="chapter" data-level="D.1.2" data-path="section-28.html"><a href="section-28.html#section-35"><i class="fa fa-check"></i><b>D.1.2</b> 이해관계 선언</a></li>
<li class="chapter" data-level="D.1.3" data-path="section-28.html"><a href="section-28.html#section-36"><i class="fa fa-check"></i><b>D.1.3</b> 운영</a></li>
</ul></li>
<li class="chapter" data-level="D.2" data-path="section-28.html"><a href="section-28.html#section-39"><i class="fa fa-check"></i><b>D.2</b> 지침이 다루는 인구 집단</a></li>
<li class="chapter" data-level="D.3" data-path="section-28.html"><a href="section-28.html#section-40"><i class="fa fa-check"></i><b>D.3</b> 지침 사용 대상자</a></li>
<li class="chapter" data-level="D.4" data-path="section-28.html"><a href="section-28.html#section-41"><i class="fa fa-check"></i><b>D.4</b> 지침의 범위와 목적</a></li>
<li class="chapter" data-level="D.5" data-path="section-28.html"><a href="section-28.html#section-42"><i class="fa fa-check"></i><b>D.5</b> 지침의 목적</a></li>
<li class="chapter" data-level="D.6" data-path="section-28.html"><a href="section-28.html#section-43"><i class="fa fa-check"></i><b>D.6</b> 외부 검토</a><ul>
<li class="chapter" data-level="" data-path="section-28.html"><a href="section-28.html#section-44"><i class="fa fa-check"></i>잠재적 승인기구</a></li>
</ul></li>
<li class="chapter" data-level="D.7" data-path="section-28.html"><a href="section-28.html#section-45"><i class="fa fa-check"></i><b>D.7</b> 보급전략</a></li>
<li class="chapter" data-level="D.8" data-path="section-28.html"><a href="section-28.html#section-46"><i class="fa fa-check"></i><b>D.8</b> 갱신절차</a></li>
<li class="chapter" data-level="D.9" data-path="section-28.html"><a href="section-28.html#section-47"><i class="fa fa-check"></i><b>D.9</b> 편집의 독립성과 재정</a></li>
</ul></li>
<li class="chapter" data-level="E" data-path="section-48.html"><a href="section-48.html"><i class="fa fa-check"></i><b>E</b> 범위결정과 핵심질문</a><ul>
<li class="chapter" data-level="E.1" data-path="section-48.html"><a href="section-48.html#section-49"><i class="fa fa-check"></i><b>E.1</b> 범위결정</a></li>
<li class="chapter" data-level="E.2" data-path="section-48.html"><a href="section-48.html#section-50"><i class="fa fa-check"></i><b>E.2</b> 핵심질문</a><ul>
<li class="chapter" data-level="E.2.1" data-path="section-48.html"><a href="section-48.html#section-51"><i class="fa fa-check"></i><b>E.2.1</b> 선정과정</a></li>
<li class="chapter" data-level="E.2.2" data-path="section-48.html"><a href="section-48.html#section-52"><i class="fa fa-check"></i><b>E.2.2</b> 최종 선정된 핵심질문</a></li>
</ul></li>
</ul></li>
<li class="chapter" data-level="F" data-path="section-53.html"><a href="section-53.html"><i class="fa fa-check"></i><b>F</b> 개발의 엄격성</a><ul>
<li class="chapter" data-level="F.1" data-path="section-53.html"><a href="section-53.html#section-54"><i class="fa fa-check"></i><b>F.1</b> 개발방법</a></li>
<li class="chapter" data-level="F.2" data-path="section-53.html"><a href="section-53.html#section-55"><i class="fa fa-check"></i><b>F.2</b> 지침및 근거검색</a></li>
<li class="chapter" data-level="F.3" data-path="section-53.html"><a href="section-53.html#section-56"><i class="fa fa-check"></i><b>F.3</b> 검색된 진료지침및 연구결과 선별</a></li>
<li class="chapter" data-level="F.4" data-path="section-53.html"><a href="section-53.html#section-57"><i class="fa fa-check"></i><b>F.4</b> 검색된 진료지침및 연구결과 평가</a></li>
<li class="chapter" data-level="F.5" data-path="section-53.html"><a href="section-53.html#section-58"><i class="fa fa-check"></i><b>F.5</b> 권고문 합의및 권고등급 결정</a><ul>
<li class="chapter" data-level="" data-path="section-53.html"><a href="section-53.html#grade--"><i class="fa fa-check"></i>근거수준과 권고등급의 평가: GRADE 방식 사용</a></li>
</ul></li>
</ul></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">삽화편두통 예방치료약물 진료지침</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="section-48" class="section level1">
<h1><span class="header-section-number">E</span> 범위결정과 핵심질문</h1>
<div id="section-49" class="section level2">
<h2><span class="header-section-number">E.1</span> 범위결정</h2>
<ul>
<li><p>Population: Adult with frequent and/or moderate-to-severe episodic migraine</p></li>
<li><p>Intervention: Drug</p>
<ul>
<li>Anti-epileptic drug</li>
<li>Beta blocker/CCB/ARB/ACE</li>
<li>Anti-Depressant</li>
</ul></li>
<li><p>Professional:</p>
<ul>
<li>Primary care physician, Nurse, and healthcare professionals</li>
</ul></li>
<li><p>Outcome: The frequency of migraine prevention drug prescription as suggested</p></li>
<li><p>Healthcare setting: Primary care setting in Korea</p></li>
</ul>
</div>
<div id="section-50" class="section level2">
<h2><span class="header-section-number">E.2</span> 핵심질문</h2>
<div id="section-51" class="section level3">
<h3><span class="header-section-number">E.2.1</span> 선정과정</h3>
<ul>
<li><p>핵심질문 및 관련 검색어를 실무위원회에서 일차적으로 작성후 개발위원회에서 취합하여 검토 후 최종 선정하였다.</p></li>
<li><p>진료지침의 최종 권고안은 핵심질문을 기반으로 도출하였다.</p></li>
<li><p>핵심질문은 대상 환자·인구집단(P, patient population), 중재법(I, intervention), 비교 중재법(C, comparator), 중재결과(O, outcome) 내용을 구체적으로 포함하였다.</p>
<ul>
<li>대상 환자·인구집단: 대상 환자·인구집단의 연령, 성별, 임상적 특성 및 증상, 특정 질환에 대한 이력, 이전 치료 등의 구체적 특성을 하위집단 개념으로 최대한 구분하여 기술하였다.<br />
</li>
<li>중재법: 대상 중재법을 편두통 예방약물의 기전에 따라 5개의 군으로 정의하였다.</li>
<li>비교 중재법: 편두통 예방약물의 효과를 판정하기 위해 위약의 효과와 비교하였다. 핵심질문에 따라 포함되지 않는 경우도 있었다.</li>
<li>중재결과: 예방 치료의 목적 대상이 되는 해당 중재법의 임상적 주요 결과(두통 발작 일수의 감소, 강도의 감소) 등을 기술하였다.</li>
</ul></li>
<li><p>검색어</p>
<ul>
<li>핵심질문의 PICO에 해당하는 영문 검색어를 정리하였다.</li>
<li>실무위원회에서 선정된 핵심질문 및 검색어는 아래와 같은 서식을 활용하여 정리하였으며, 관련 진료지침을 검색하기 위하여 정리된 결과물을 개발위원회에 제공하였다.</li>
</ul></li>
</ul>
</div>
<div id="section-52" class="section level3">
<h3><span class="header-section-number">E.2.2</span> 최종 선정된 핵심질문</h3>
<ol style="list-style-type: decimal">
<li><p>Episodic migraine환자에서 예방치료를 고려해야 하는 요인들(두통빈도, 두 통강도, 환자의 선호도, ADL에 대한 영향 등)은 무엇인가?</p></li>
<li><p>예방치료를 진행중인 episodic migraine환자에서 치료의 중단은 어떻게 결 정해야 하는가?</p></li>
<li><p>Episodic migraine환자에서 예방치료로 베타차단제(beta blocker: propranolol 등)를 사용하는 것이 타약제, 위약 또는 치료하지 않는 것에 비해 두통의 완화에 효과적인가?</p></li>
<li><p>Episodic migraine환자에서 예방치료로 칼슘채널차단제(calcium channel blocker: flunarizine 등)를 사용하는 것이 타약제, 위약 또는 치료하지 않는 것에 비해 두통의 완화에 효과적인가?</p></li>
<li><p>Episodic migraine환자에서 예방치료로 안지오텐신전환효소억제제(angiotensin converting enzyme inhibitor)나 안지오텐신수용체차단제(angiotensin receptor blocker: candesartan 등)를 사용하는 것이 타약제, 위약 또는 치료 하지 않는 것에 비해 두통의 완화에 효과적인가?</p></li>
<li><p>Episodic migraine환자에서 예방치료로 항우울제(anti-depressant: amitryptiline 등)를 사용하는 것이 타약제, 위약 또는 치료하지 않는 것에 비해 두통의 완화에 효과적인가?</p></li>
<li><p>Episodic migraine환자에서 예방치료로 항경련제(anti-epileptic agent: divalproex sodium, sodium valproate, topiramate 등)를 사용하는 것이 타약제, 위약 또는 치료하지 않는 것에 비해 두통의 완화에 효과적인가?</p></li>
</ol>
<!-- ## Drugs -->
<!-- - Beta blocker -->
<!--     - propranolol  -->
<!--     - Metoprolol  -->
<!--     - Timolol -->
<!--     - Atenolol -->
<!--     - Nadolol  -->
<!--     - Nebivolol  -->
<!--     - Pindolol -->
<!-- - Calcium channel blocker -->
<!--     - flunarizine  -->
<!--     - cinnarizine  -->
<!--     - verapamil  -->
<!--     - nicardipine -->
<!-- - angiotensin converting enzyme inhibitor or angiotensin receptor blocker -->
<!--     - Lisinopril -->
<!--     - candesartan -->
<!-- - anti-depressant -->
<!--     - amitryptiline  -->
<!--     - nortriptyline  -->
<!--     - Venlafaxine  -->
<!--     - Fluoxetine -->
<!-- - anti-epileptic agent -->
<!--     - divalproex sodium  -->
<!--     - sodium valproate  -->
<!--     - topiramate -->
<!--     - Carbamazepine -->
<!--     - Gabapentin -->

</div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="section-28.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="section-53.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/rstudio/bookdown-demo/edit/master/09-ScopeKQ.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"download": ["MigrainePrevention.pdf", "MigrainePrevention.epub"],
"toc": {
"collapse": "subsection"
}
});
});
</script>

</body>

</html>
